Oct 20 (Reuters) – Verrica Pharmaceuticals Inc: * VERRICA PHARMACEUTICALS RECEIVES POSITIVE FEEDBACK FROM THE EUROPEAN MEDICINES AGENCY (EMA) SUPPORTING A CLEAR REGULATORY PATH FORWARD TO FILE FOR APPROVAL OF YCANTH® IN THE EUROPEAN UNION * VERRICA PHARMACEUTICALS INC – PLANS REGULATORY SUBMISSION FOR YCANTH BY Q4 2026 Source text: Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Danielle Broadway LOS ANGELES, Feb 5 (Reuters) - Bill Nye, the pop culture science…
VIDEO SHOWS: ITALIAN FANS ARRIVING AT ICE HOCKEY STADIUM FOR THE WOMEN'S GAME BETWEEN ITALY…
By Prakhar Srivastava Feb 5 (Reuters) - Gemini Space Station, the cryptocurrency exchange founded by…
VIDEO SHOWS: HIGHLIGHTS FROM ICE HOCKEY AND CURLING MIXED DOUBLES ROUND ROBIN SESSION 2 RESENDING…
By Medha Singh Feb 5 (Reuters) - Shares of U.S. software and data services companies…
By Sam Tobin LONDON, Feb 5 (Reuters) - British singer Elton John's husband, David Furnish,…